Cargando…
Imaging mass spectrometry in drug development and toxicology
During the last decades, imaging mass spectrometry has gained significant relevance in biomedical research. Recent advances in imaging mass spectrometry have paved the way for in situ studies on drug development, metabolism and toxicology. In contrast to whole-body autoradiography that images the lo...
Autores principales: | Karlsson, Oskar, Hanrieder, Jörg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429351/ https://www.ncbi.nlm.nih.gov/pubmed/27933369 http://dx.doi.org/10.1007/s00204-016-1905-6 |
Ejemplares similares
-
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
por: Hanrieder, Jörg, et al.
Publicado: (2012) -
Mass Spectrometry Applications for Toxicology
por: Mbughuni, Michael M., et al.
Publicado: (2016) -
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
por: Wehrli, Patrick M., et al.
Publicado: (2019) -
Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease
por: Ljungdahl, Anna, et al.
Publicado: (2011) -
l-DOPA-induced Dyskinesia is Associated with Regional Increase of Striatal Dynorphin Peptides as Elucidated by Imaging Mass Spectrometry
por: Hanrieder, Jörg, et al.
Publicado: (2011)